Loading…
SI-BONE, Inc. is projected to rise to $19.78 by 2027, a +37% move from its current price of $14.46. SIBN is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $14.06 | $14.47 | $14.89 | +0.07% |
| May 30 | $13.90 | $14.48 | $15.08 | +0.14% |
| May 31 | $13.78 | $14.49 | $15.23 | +0.21% |
| Jun 1 | $13.68 | $14.50 | $15.36 | +0.28% |
| Jun 2 | $13.60 | $14.51 | $15.48 | +0.34% |
| Jun 3 | $13.53 | $14.52 | $15.59 | +0.41% |
| Jun 4 | $13.46 | $14.53 | $15.69 | +0.48% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $13.46 | $14.53 | $15.69 | +0.48% |
| Week 2 | $13.10 | $14.60 | $16.27 | +0.97% |
| Week 3 | $12.85 | $14.67 | $16.75 | +1.45% |
| Week 4 | $12.65 | $14.74 | $17.18 | +1.94% |
| Week 5 | $12.48 | $14.81 | $17.58 | +2.44% |
| Week 6 | $12.34 | $14.88 | $17.95 | +2.93% |
| Week 7 | $12.21 | $14.96 | $18.31 | +3.43% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
SI-BONE, Inc. is a medical device company that develops procedural solutions for compromised bone, grounded in biomechanical design and anatomy-specific applications in the United States and internationally. It offers a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products.
The company also provides IFUSE, a triangular titanium implant with a triangular cross-section and porous surface that stabilizes the joint and facilitates the biological fixation of the bone onto the implant to drive fusion; IFUSE 3D, a triangular titanium implant with a porous surface and fenestrated design to self-harvest bone; IFUSE BONE, which supports and augments the patient’s own bone tissue in orthopedic procedures; IFUSE TORQ, an additively-manufactured threaded implant designed to allow for osteointegration, or incorporation of the bone into the implant’s porous surface and structure; IFUSE BEDROCK GRANITE, an implant with a machined titanium core and a tulip that attaches to the rod and provides fusion and fixation to the sacroiliac joint as a foundational element for segmental spinal fusion; and IFUSE TORQ TNT, a porous threaded design with lengths capable of spanning the posterior pelvis, passing through the ipsilateral ilium, sacrum, and through the contralateral ilium. The company markets its products primarily with a direct sales force, as well as through third-party sales agents and resellers. SI-BONE, Inc.
was incorporated in 2008 and is headquartered in Santa Clara, California.
SI-BONE, Inc. (SIBN) is currently priced at $14.68, with a market cap of $651.05M and a rank of 2842. The current price sits within a set of forecasted movements that point to a rising long-term path, with multi-year estimates showing substantial upside through 2050.
Today’s price is the anchor for a projected journey to higher averages across the next several years.
A major floor 28.0% below — a decisive break under it would weaken the trend.
The nearest floor, 19.7% below — buyers have tended to step in here.
Price is pressing into resistance (2.6% away) — a breakout level to watch.
A major ceiling 18.5% above — clearing it would confirm fresh momentum.
Key SIBN support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of SIBN market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $14.69 | Sell | $14.59 | Sell |
| MA 10 | $14.60 | Sell | $14.40 | Buy |
| MA 20 | $13.71 | Buy | $14.05 | Buy |
| MA 50 | $13.45 | Buy | $13.99 | Buy |
| MA 100 | $14.87 | Sell | $14.63 | Sell |
| MA 200 | $15.78 | Sell | $15.35 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 55.52 | Neutral |
| Stoch RSI (14) | 82.63 | Sell |
| CCI (20) | 55.28 | Neutral |
| Williams %R (14) | -11.76 | Info |
| MACD (12,26,9) | 0.12 | Buy |
| ROC (12) | 17.85 | Buy |
| Bollinger %B (20,2) | 0.68 | Neutral |
| Stochastic %K (14) | 88.24 | Sell |
| TRIX (15) | 0.26 | Buy |
| Awesome (5,34) | 0.99 | Buy |
| Ultimate (7,14,28) | 62.16 | Neutral |
| Momentum (10) | 0.56 | Buy |
| Aroon Osc (25) | 24.00 | Buy |
| Hull MA (9) | 14.66 | Sell |
| ADX (14) | 15.61 | Neutral |
| ATR (14) | 0.36 | Info |
The 30-day technical picture shows bullish sentiment with RSI(14) at 60. The stock trades near key moving averages: SMA50 at $13.39 and SMA200 at $15.80. Support is tagged at $11.61 and resistance at $14.84, while the 30-day range spans $12.00 to $17.97.
The current price of $14.68 sits between these short-term levels, highlighting a constructive near-term setup.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $11.61 | $14.46 | $20.55 | 0% | Neutral | |
| $15.60 | $19.78 | $26.63 | +37% | Bullish | |
| $17.70 | $23.10 | $32.29 | +60% | Bullish | |
| $17.07 | $22.83 | $32.87 | +58% | Bullish | |
| $17.89 | $24.45 | $36.09 | +69% | Bullish | |
| $17.59 | $24.53 | $37.01 | +70% | Bullish | |
| $17.23 | $24.47 | $37.65 | +69% | Bullish | |
| $21.45 | $30.99 | $48.54 | +114% | Bullish | |
| $23.60 | $34.66 | $55.20 | +140% | Bullish | |
| $24.01 | $35.83 | $57.93 | +148% | Bullish | |
| $29.70 | $47.64 | $82.10 | +229% | Bullish | |
| $48.37 | $87.95 | $166.36 | +508% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $11.61 | $14.46 | $17.00 | +0.00% |
| June 2026 | $12.76 | $15.01 | $18.08 | +3.80% |
| July 2026 | $12.98 | $15.40 | $18.82 | +2.58% |
| August 2026 | $12.74 | $15.22 | $18.81 | -1.12% |
| September 2026 | $12.98 | $15.60 | $19.44 | +2.44% |
| October 2026 | $13.55 | $16.37 | $20.57 | +4.94% |
| November 2026 | $13.48 | $16.36 | $20.70 | -0.06% |
| December 2026 | $13.23 | $16.13 | $20.55 | -1.38% |
Click any year to see its month-by-month SIBN forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect SIBN to range from $11.61 to $20.55 through 2026. The $14.46 average target implies a 0% move from current prices. A consolidation phase looks the most probable path here.
The SIBN price prediction for 2027 points to an average of $19.78 (low $15.60, high $26.63) — a potential gain of +37% on today's $14.46. Momentum favours further upside here.
In 2028, SIBN is projected to trade between $17.70 and $32.29, averaging $23.10 — a potential gain of +60% from today's $14.46. That is up +17% on the projected 2027 average. Buyers look set to stay in control over this stretch.
SI-BONE, Inc.'s 2029 outlook centres on $22.83, within a $17.07 to $32.87 range. That is -1% versus the projected 2028 average. That marks a +58% change versus current levels. Momentum favours further upside here.
By 2030, SIBN could reach as high as $36.09, with a base case around $24.45 and support toward $17.89 — roughly +69% from $14.46. Buyers look set to stay in control over this stretch.
Expect SIBN to range from $17.59 to $37.01 through 2031. The $24.53 average target implies a +70% move from current prices. That is up 0% on the projected 2030 average. Momentum favours further upside here.
The SIBN price prediction for 2032 points to an average of $24.47 (low $17.23, high $37.65) — a potential gain of +69% on today's $14.46. Buyers look set to stay in control over this stretch.
In 2033, SIBN is projected to trade between $21.45 and $48.54, averaging $30.99 — a potential gain of +114% from today's $14.46. That is up +27% on the projected 2032 average. Momentum favours further upside here.
SI-BONE, Inc.'s 2034 outlook centres on $34.66, within a $23.60 to $55.20 range. That is up +12% on the projected 2033 average. That marks a +140% change versus current levels. Buyers look set to stay in control over this stretch.
By 2035, SIBN could reach as high as $57.93, with a base case around $35.83 and support toward $24.01 — roughly +148% from $14.46. Momentum favours further upside here.
Expect SIBN to range from $29.70 to $82.10 through 2040. The $47.64 average target implies a +229% move from current prices. That is up +33% on the projected 2035 average. Buyers look set to stay in control over this stretch.
The SIBN price prediction for 2050 points to an average of $87.95 (low $48.37, high $166.36) — a potential gain of +508% on today's $14.46. Momentum favours further upside here.
Investing $1,000 in SIBN today (≈ 69.156293 SIBN) could be worth
$6,082.5
+$5,082.5 (+508%) by 2050 · US Dollar
Based on the average projected SIBN price of $87.95 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in SIBNwould be worth at today's price.
$1,000 invested in SIBN on May 27, 2025 (≈ 53.792361 SIBN) would be worth
$777.84
-$222.16 (-22.2%) today · 0.78× · US Dollar
Based on a SIBN entry price of $18.59 vs. today's $14.46.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $14.82 | $975.71 | -2.4% |
| 1 month ago | $13.15 | $1,099.62 | +10.0% |
| 3 months ago | $16.23 | $890.94 | -10.9% |
| 6 months ago | $19.46 | $743.06 | -25.7% |
| 1 year ago | $18.59 | $777.84 | -22.2% |
| All time (5.0y) ago | $31.04 | $465.85 | -53.4% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our SIBN forecast.
Our base-case forecast reaches $29.00 around 2033.
Implied market cap at $29.00: $1.29B
The multi-year forecast paints a clearly bullish trajectory. In 2027 the expected average price is $20.39 with a max of $27.69 and a min of $15.97, representing a 38.9% ROI and a bullish sentiment. The path continues higher with 2028 averaging $23.74 (max $33.52, min $18.03) and a 61.7% ROI, followed by 2029 at $23.41 average (max $34.10, min $17.33) for a 59.5% ROI.
By 2030 the average is $25.04 with a 70.6% ROI (min $18.11, max $37.44). 2031 and 2032 show averages of $24.87 and $24.88 with ROIs of 69.4% and 69.5% respectively. The bullish trend strengthens in 2033 (avg $31.86, ROI 117) and 2034 (avg $35.37, ROI 140.9) and extends into 2035 (avg $36.66, ROI 149.7).
The long arc includes 2040 (avg $48.43, ROI 229.9) and culminates in 2050 (avg $89.71, ROI 511.1). These figures illustrate a rising price path and escalating ROI across decades, with a consistent bullish sentiment.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $25.04, with a min of $18.11 and a max of $37.44; ROI of 70.6% and a bullish sentiment.
Forecasts imply a rising average price from $14.68 in 2026 to $89.71 by 2050, with ROI climbing to 511.1% in 2050 and a bullish sentiment in later years. These are estimates and not guaranteed.
Yes. The forecast for 2035 shows a max of $60.26, indicating it can reach the $60 level in that year.
RSI(14) is 60, the SMA50 is $13.39, and the SMA200 is $15.80. Support sits at $11.61 and resistance at $14.84, with a 30-day price range of $12.00 to $17.97.
Current price is $14.68 and market cap is $651.05M.
SI-BONE, Inc. Community Discussion
0Share your SI-BONE, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.